ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,295
-0,18%
Bitcoin
70 160,09
0,04%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Quoin Pharmaceuticals Ltd (QNRX)

  7. Quoin Pharmaceuticals Ltd (QNRX) Actualités

QNRX Quoin Pharmaceuticals Ltd

0,78
0,0149 (1,95%)
22 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Quoin Pharmaceuticals Ltd QNRX NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0149 1,95% 0,78 01:55:48
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,7536 0,75 0,79 0,7501 0,7651
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/5/202422:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202414:30GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
08/5/202422:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202422:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
13/3/202421:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
13/3/202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
08/3/202422:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202422:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202422:01EDGAR2Form 8-K - Current report
07/3/202422:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
06/3/202423:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
06/3/202422:01EDGAR2Form 8-K - Current report
05/3/202414:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
04/3/202423:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/3/202414:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
27/2/202412:01EDGAR2Form DEF 14A - Other definitive proxy statements
15/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202402:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:50EDGAR2Form S-1/A - General form for registration of securities..
13/2/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
12/2/202423:12EDGAR2Form S-1 - General form for registration of securities under..
08/2/202414:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
30/1/202422:05EDGAR2Form 8-K - Current report
18/12/202323:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/12/202323:29EDGAR2Form 8-K - Current report
13/12/202314:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
09/11/202323:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202323:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202323:10EDGAR2Form 8-K - Current report
08/11/202323:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
07/11/202323:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/11/202322:17EDGAR2Form 8-K - Current report
03/11/202313:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
01/11/202322:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/11/202321:59EDGAR2Form 8-K - Current report
30/10/202321:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202315:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
24/10/202314:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
19/10/202323:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/9/202322:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/9/202312:03EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202319:38EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202322:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/8/202320:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202323:01EDGAR2Form 8-K - Current report
02/8/202322:45GLOBEQuoin Pharmaceuticals Provides Corporate Update and..

Dernières Valeurs Consultées

NASDAQ
QNRX
Quoin Pharmaceuticals
LSE
38AS
Adcb Fin 5.00%
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés